HPV16-E711-19 peptide vaccine DPX-E7

{
  "id": "MLC-T-ONC-014193",
  "term": "HPV16-E711-19 peptide vaccine DPX-E7",
  "field": "Oncology and biomedicine",
  "definition": "A therapeutic vaccine composed of a synthetic peptide consisting of amino acids 11 through 19 of the viral oncoprotein human papillomavirus (HPV) subtype 16 E7 (HPV16-E7 11-19), with potential antineoplastic and immunostimulating activities. Immunization with the DPX-E7 HPV vaccine may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the HPV16-E7 protein. HPV type 16 plays a key role in the carcinogenesis of certain cancers.",
  "synonyms": [
    "DPX-E7 vaccine",
    "HPV16-E7 11-19 vaccine",
    "HPV16-E7 11-19 nanomer vaccine DPX-E7"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/hpv16-e711-19-peptide-vaccine-dpx-e7/"
}